The worst Ebola virus disease outbreak in history ended in 2016 after infecting 28,600 people and killing about 11,300 worldwide.
The outbreak led to urgent action by medical experts across the world to combat this devastating disease; including the setting up of trials of vaccines to stop the disease taking hold.
This global commitment to develop a vaccine against the disease suggested eight options, out of a starting pool of 15 candidates, should be evaluated in clinical trials worldwide by the end of 2015.
Professor Sanjeev Krishna, of St George’s University of London’s Institute for Infection and Immunity, said: “An unprecedented Ebola outbreak showed how it is possible for academics, non-governmental organisations, industry and funders to work effectively together very quickly in times of medical crisis. The results of the trial show how a vaccine could best be used to tackle this terrible disease effectively.
“We need a system of specialists, medical experts and organisers that maintains vigilance against outbreak diseases like Ebola.
“We should continue to improve ways to make, evaluate and deliver vaccines when they are needed, often in parts of the world lacking in infrastructure for diagnosing infections and providing treatments.”
He explained that considering the persistent replication of the vaccine which is called rVSV-?GP-ZEBOV in children and adolescents, further studies investigating lower doses in this population are warranted.
The vaccine contains a non-infectious portion of a gene from the Zaire Ebola virus. The St George’s researchers worked with colleagues on a vaccine trial in Gabon.
In addition, lower vaccine doses should be considered when boosting individuals with pre-existing antibodies to Ebolavirus glycoprotein, a finding that has emerged after the vaccine was tested in a country that has experienced Ebolavirus outbreaks in the past.
The vaccine was one of two being examined as a ‘candidate’ option by the World Health Organisation to identify urgently a vaccine to combat the Ebola virus outbreak in West Africa.
The clinical trial was led by colleagues at University of Tübingen in Germany, coordinated by Professor Peter Kremsner with their partner institute CERMEL in Lambaréné, Gabon.
Learn more: Ebola vaccine tested in adults and children in Africa hailed a success
The Latest on: Ebola vaccine
[google_news title=”” keyword=”Ebola vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Deadly Ebola-like Marburg virus spreads to Equatorial Guinea's commercial capital of Bataon March 27, 2023 at 7:51 am
A deadly outbreak of the Marburg virus, which causes symptoms similar to Ebola, has spread from rural districts in Equatorial Guinea to the country's commercial capital. The outbreak in the West ...
- What Is Marburg? What You Need To Know About The Killer Ebola-Like Virus Spreading In Parts Of Africaon March 27, 2023 at 5:03 am
There are no treatments or vaccines approved for Marburg, a virus in the same family as Ebola with a fatality rate between 24% to 88%.
- 2023-2029 Ebola Virus Vaccine Market Size (Share and Outlook) with In-depth Analysis SWOT Analysis | Research Report by Absolute Reportson March 27, 2023 at 4:19 am
Mar 27, 2023 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global "Ebola Virus Vaccine Market" ...
- Ebola's exponential growthon March 26, 2023 at 5:00 pm
Until and unless a vaccine becomes available in very large quantities, the only way to stop the exponential spread of Ebola in the affected countries is to isolate the victims, a task that is very ...
- WHO Begins Clinical Trials for Ebola Vaccineon March 26, 2023 at 5:00 pm
The start of vaccine trials will mark a pivotal moment towards the development of an effective tool against the virus behind the current Ebola outbreak in Uganda,” Moeti said. She expressed hope ...
- Marburg Virus In Africa: 7 Unusual Symptoms of This Ebola-Like Virus You Must Knowon March 26, 2023 at 11:45 am
The ebola-like virus is spreading fast across Africa. Known by the name Marburg virus disease, it is extremely rare in nature and has the ability to cause high fatality rate.
- Marburg virus in Africa: How dangerous is it, know symptoms of Ebola-like viruson March 26, 2023 at 10:53 am
Marburg virus is in the same family as the virus that causes Ebola It is a highly virulent disease that causes hemorrhagic fever ...
- Eight new cases of Ebola-like virus reported as double outbreak hits Africaon March 24, 2023 at 4:24 pm
World Health Organisation moves to fast-track testing of vaccines after Marburg virus claims five lives, including one health worker ...
- Lessons learned during Ebola crisis can help manage Marburg outbreak, says experton March 24, 2023 at 6:25 am
The Marburg virus—a rare but severe hemorrhagic fever which affects both people and non-human primates—belongs to the same family of viruses as Ebola. The disease presents wit ...
- Risk Ebola-like Marburg virus will ‘spread internationally’, scientists warn – as up to 32 deadon March 24, 2023 at 4:24 am
ONE of the world’s most deadly viruses could soon spread internationally, health officials have warned. The Marburg virus, which is similar to Ebola, causes those who catch it to ...
via Google News and Bing News